SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001410578-23-002143
Filing Date
2023-10-12
Accepted
2023-10-12 16:15:57
Documents
133
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A cvac-20221231x20fa.htm   iXBRL 20-F/A 3009278
2 EX-12.1 cvac-20221231xex12d1.htm EX-12.1 11516
3 EX-12.2 cvac-20221231xex12d2.htm EX-12.2 12277
4 EX-13.1 cvac-20221231xex13d1.htm EX-13.1 5448
5 EX-13.2 cvac-20221231xex13d2.htm EX-13.2 5303
6 EX-15.1 cvac-20221231xex15d1.htm EX-15.1 5051
7 GRAPHIC cvac-20221231x20fa003.jpg GRAPHIC 9791
  Complete submission text file 0001410578-23-002143.txt   16677530

Data Files

Seq Description Document Type Size
8 EX-101.SCH cvac-20221231.xsd EX-101.SCH 162509
9 EX-101.CAL cvac-20221231_cal.xml EX-101.CAL 92722
10 EX-101.DEF cvac-20221231_def.xml EX-101.DEF 544696
11 EX-101.LAB cvac-20221231_lab.xml EX-101.LAB 1031380
12 EX-101.PRE cvac-20221231_pre.xml EX-101.PRE 852570
127 EXTRACTED XBRL INSTANCE DOCUMENT cvac-20221231x20fa_htm.xml XML 3677866
Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Filer) CIK: 0001809122 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-39446 | Film No.: 231322900
SIC: 2834 Pharmaceutical Preparations